US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 3.630
  • -0.270-6.92%
Close Apr 25 16:00 ET
  • 3.690
  • +0.060+1.65%
Post 16:18 ET
1.06BMarket Cap-7117P/E (TTM)

About AbCellera Biologics Company

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Company Profile

SymbolABCL
Company NameAbCellera Biologics
Listing DateDec 11, 2020
Issue Price20.00
Founded2012
CEODr. Carl L.G. Hansen, PhD
MarketNASDAQ
Employees586
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2215 Yukon Street
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Y 0A1
Phone1-604-559-9005
Websitehttp://www.abcellera.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carl L.G. Hansen, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 8.80M
  • Tryn Stimart
  • Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
  • 3.68M
  • Dr. Veronique Lecault, PhD
  • Director and Chief Operating Officer
  • 4.69M
  • Andrew Booth
  • Chief Financial Officer and Principal Accounting Officer
  • 4.89M
  • Neil Aubuchon
  • Chief Commercial Officer
  • 5.61M
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 72.50K
  • Dr. Andrew W. Lo
  • Independent Director
  • 50.00K
  • Dr. Michael Hayden, Ch.B.,M.B.,PhD
  • Lead Independent Director
  • 100.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg